Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HCG Manavata Cancer Centre (HCGMCC) is a leading, state-of-the-art oncology hospital located in Nashik, Maharashtra, India. Founded in 2007 by Dr. Raj Nagarkar and partnered with Healthcare Global Enterprises (HCG) in 2010, the 275-bed facility is Maharashtra's first NABH-accredited cancer hospital. HCGMCC provides comprehensive cancer care under one roof, including surgical oncology, medical oncology, radiation oncology, nuclear medicine, and bone marrow transplants. The center is equipped with advanced technologies such as robotic-assisted surgery systems, TomoTherapy-H, and Elekta Versa HD. Additionally, in collaboration with SunAct, HCGMCC operates a Centre of Excellence for Cell and Gene Therapy (CGT), and its clinical research arm, the Manavata Clinical Research Institute (MCRI), conducts US-FDA and DCGI-audited clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HCG Manavata Cancer Centre.